Comparative study of atropine and glycopyrrolate on suxamethonium-induced changes in cardiac rate and rhythm.

The effectiveness of atropine and glycopyrrolate in the prophylaxis of suxamethonium-induced bradycardia was evaluated in a double-blind study of 56 patients. Three had clinically demonstrable bradycardia, all having received atropine. We conclude that glycopyrrolate offered adequate protection against cardiac effects of repeated doses of suxamethonium.

RCT Entities:   Population Interventions Outcomes